Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$58,953,463
+$5,515,954 QoQ
Shares Held
234,277
-4.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#336
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $497,536,571 across 15 Drug Manufacturers - General names. ABBV ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
811,080 | $104,223,779 | |
| 2 | AMGN |
Amgen Inc
|
234,207 | $84,811,038 | |
| 3 | JNJ |
Johnson & Johnson
|
274,166 | $69,629,938 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
234,277 | $58,953,463 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
416,657 | $52,640,444 | |
| 6 | LLY |
ELI LILLY & Co
|
39,113 | $46,913,309 | |
| 7 | PFE |
Pfizer Inc
|
1,448,821 | $34,887,608 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
577,945 | $33,301,189 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,953,463 | 234,277 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $53,437,509 | 245,701 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $60,596,689 | 265,205 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $58,412,215 | 252,277 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,159,302 | 243,289 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $51,229,106 | 244,507 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $45,505,060 | 256,078 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $55,003,509 | 278,527 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $51,028,741 | 297,509 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $57,304,137 | 314,685 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $46,258,852 | 298,502 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $52,513,687 | 352,299 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,186,147 | 424,450 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $73,973,816 | 464,164 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $91,733,067 | 567,620 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $86,712,139 | 646,093 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $105,949,347 | 691,756 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $131,629,914 | 811,979 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $107,812,113 | 796,249 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $80,388,173 | 745,232 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $82,425,445 | 731,760 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $78,489,258 | 725,275 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $78,667,814 | 734,184 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $64,399,845 | 735,242 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $78,187,015 | 796,364 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $52,919,668 | 694,575 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||